Nutex Health (NASDAQ:NUTX) Given New $60.00 Price Target at Benchmark

Nutex Health (NASDAQ:NUTX - Get Free Report) had its price target upped by equities research analysts at Benchmark from $45.00 to $60.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a "buy" rating on the stock. Benchmark's price target indicates a potential upside of 66.94% from the company's previous close.

Separately, Maxim Group raised their target price on Nutex Health from $45.00 to $50.00 and gave the company a "buy" rating in a research report on Tuesday.

Nutex Health Trading Up 28.8 %

NUTX traded up $8.03 during trading hours on Tuesday, reaching $35.94. 185,953 shares of the company's stock traded hands, compared to its average volume of 42,120. The company has a quick ratio of 1.55, a current ratio of 1.59 and a debt-to-equity ratio of 3.04. The firm has a 50-day moving average price of $22.67 and a 200 day moving average price of $13.60. The firm has a market capitalization of $182.07 million, a PE ratio of -3.82 and a beta of 0.11. Nutex Health has a 52-week low of $4.16 and a 52-week high of $39.90.

Insiders Place Their Bets

In other news, CFO Jon Christian Bates bought 1,350 shares of the company's stock in a transaction that occurred on Thursday, August 22nd. The shares were purchased at an average price of $21.46 per share, with a total value of $28,971.00. Following the completion of the acquisition, the chief financial officer now directly owns 2,277 shares in the company, valued at approximately $48,864.42. This trade represents a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 38.52% of the company's stock.

Hedge Funds Weigh In On Nutex Health

A number of large investors have recently modified their holdings of NUTX. International Assets Investment Management LLC bought a new stake in shares of Nutex Health during the 3rd quarter worth about $188,000. Thompson Davis & CO. Inc. purchased a new stake in Nutex Health during the third quarter worth about $494,000. Finally, Essex Investment Management Co. LLC bought a new position in shares of Nutex Health in the third quarter valued at approximately $1,579,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.